These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

545 related articles for article (PubMed ID: 28139239)

  • 1. Long-term medical management of endometriosis with dienogest and with a gonadotropin-releasing hormone agonist and add-back hormone therapy.
    Bedaiwy MA; Allaire C; Alfaraj S
    Fertil Steril; 2017 Mar; 107(3):537-548. PubMed ID: 28139239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progestin-only pills may be a better first-line treatment for endometriosis than combined estrogen-progestin contraceptive pills.
    Casper RF
    Fertil Steril; 2017 Mar; 107(3):533-536. PubMed ID: 28162779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gonadotropin-releasing hormone agonist with add-back treatment is as effective and tolerable as dienogest in preventing pain recurrence after laparoscopic surgery for endometriosis.
    Lee DY; Lee JY; Seo JW; Yoon BK; Choi D
    Arch Gynecol Obstet; 2016 Nov; 294(6):1257-1263. PubMed ID: 27549091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of long-term use of combined oral contraceptive after gonadotropin-releasing hormone agonist plus add-back therapy versus dienogest to prevent recurrence of ovarian endometrioma after surgery.
    Seo JW; Lee DY; Kim SE; Yoon BK; Choi D
    Eur J Obstet Gynecol Reprod Biol; 2019 May; 236():53-57. PubMed ID: 30884336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Norethindrone acetate or dienogest for the treatment of symptomatic endometriosis: a before and after study.
    Vercellini P; Bracco B; Mosconi P; Roberto A; Alberico D; Dhouha D; Somigliana E
    Fertil Steril; 2016 Mar; 105(3):734-743.e3. PubMed ID: 26677792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maintenance therapy with dienogest following gonadotropin-releasing hormone agonist treatment for endometriosis-associated pelvic pain.
    Kitawaki J; Kusuki I; Yamanaka K; Suganuma I
    Eur J Obstet Gynecol Reprod Biol; 2011 Aug; 157(2):212-6. PubMed ID: 21474232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dienogest compared with gonadotropin-releasing hormone agonist after conservative surgery for endometriosis.
    Takaesu Y; Nishi H; Kojima J; Sasaki T; Nagamitsu Y; Kato R; Isaka K
    J Obstet Gynaecol Res; 2016 Sep; 42(9):1152-8. PubMed ID: 27225336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of add-back therapy in the United States.
    Olive DL
    Drugs Today (Barc); 2005 Jul; 41 Suppl A():23-6. PubMed ID: 16200222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Maintenance therapy for endometriosis].
    Kitawaki J
    Nihon Rinsho; 2010 Jan; 68(1):163-7. PubMed ID: 20077811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Management of painful endometriosis in adolescents: CNGOF-HAS Endometriosis Guidelines].
    Sauvan M; Chabbert-Buffet N; Geoffron S; Legendre G; Wattier JM; Fernandez H
    Gynecol Obstet Fertil Senol; 2018 Mar; 46(3):264-266. PubMed ID: 29519595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dienogest vs GnRH agonists as postoperative therapy after laparoscopic eradication of deep infiltrating endometriosis with bowel and parametrial surgery: a randomized controlled trial.
    Ceccaroni M; Clarizia R; Liverani S; Donati A; Ceccarello M; Manzone M; Roviglione G; Ferrero S
    Gynecol Endocrinol; 2021 Oct; 37(10):930-933. PubMed ID: 34036845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of medical treatments for endometriosis.
    Berlanda N; Somigliana E; Viganò P; Vercellini P
    Expert Opin Drug Saf; 2016 Jan; 15(1):21-30. PubMed ID: 26576479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dienogest reduces endometrioma volume and endometriosis-related pain symptoms.
    Uludag SZ; Demirtas E; Sahin Y; Aygen EM
    J Obstet Gynaecol; 2021 Nov; 41(8):1246-1251. PubMed ID: 33629621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current approaches to optimizing the treatment of endometriosis in adolescents.
    Laufer MR
    Gynecol Obstet Invest; 2008; 66 Suppl 1():19-27. PubMed ID: 18936548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Add-back therapy in the treatment of endometriosis-associated pain.
    Zupi E; Marconi D; Sbracia M; Zullo F; De Vivo B; Exacustos C; Sorrenti G
    Fertil Steril; 2004 Nov; 82(5):1303-8. PubMed ID: 15533351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New medical treatments for painful endometriosis: CNGOF-HAS Endometriosis Guidelines].
    Legendre G; Delbos L; Hudon E; Chabbert-Buffet N; Geoffron S; Sauvan M; Fernandez H; Bouet PE; Descamps P
    Gynecol Obstet Fertil Senol; 2018 Mar; 46(3):256-263. PubMed ID: 29530558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GnRH analogs: options for endometriosis-associated pain treatment.
    Batzer FR
    J Minim Invasive Gynecol; 2006; 13(6):539-45. PubMed ID: 17097577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging drugs for endometriosis.
    Fedele L; Berlanda N
    Expert Opin Emerg Drugs; 2004 May; 9(1):167-77. PubMed ID: 15155142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of endometriosis].
    Römer T
    Med Monatsschr Pharm; 2012 Feb; 35(2):44-51; quiz 53-4. PubMed ID: 22400429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medical management of endometriosis.
    Alonso A; Gunther K; Maheux-Lacroix S; Abbott J
    Curr Opin Obstet Gynecol; 2024 Oct; 36(5):353-361. PubMed ID: 39159261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.